Summary & Overview
CPT 83520: Immunoassay Measurement of Non-Infectious Analyte
CPT code 83520 covers immunoassay measurement of analytes that are not infectious agent antibodies or antigens when no more specific CPT code applies. Nationally, this code matters because it provides a crosswalk for laboratory immunoassays that lack a dedicated code, affecting billing consistency and claims processing for clinical laboratories and hospital labs. Payers commonly involved in coverage and reimbursement for this code include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what CPT code 83520 represents, the clinical and laboratory context in which it is used, and the types of benchmarks and policy considerations typically associated with unspecified analyte immunoassays. The publication covers billing practice implications, common modifier usage (listed separately), typical sites of service such as clinical and hospital laboratories, and where data is limited. The summary highlights that this code is applied based on methodology (immunoassay) and analyte type rather than a named test, which influences coding decisions and payer adjudication. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 83520 describes an immunoassay measurement of a non-infectious-agent analyte performed by a laboratory analyst. This code is used when the analyte tested is not an infectious agent antibody or antigen and no more specific CPT code exists for that analyte. The procedure is defined by the immunoassay methodology and the nature of the analyte being measured.
Service type: Laboratory / Clinical Pathology service
Typical site of service: Clinical laboratory or hospital laboratory setting, including independent reference labs that perform immunoassays.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A middle-aged outpatient presents to the ambulatory laboratory at a hospital-owned pathology service with nonspecific symptoms such as fatigue and weight loss. The clinician orders an immunoassay to measure a non-infectious analyte (for example, a therapeutic drug level, hormone, or tumor marker) for which there is no analyte-specific CPT code. A phlebotomist collects blood using standard venipuncture; the specimen is labeled and sent to the core immunology/chemistry laboratory. A medical technologist performs an immunoassay using instrument platform-specific reagents and measures the analyte concentration. The laboratory documents analytic method, calibration, controls, and result interpretation in the patient record. Billing uses 83520 when the test meets immunoassay methodology criteria and no more specific CPT code exists. Typical site of service is an outpatient clinical laboratory or hospital laboratory; the service type is a laboratory clinical diagnostic immunoassay measuring a non-infectious analyte.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the professional interpretation component if applicable to laboratory/consultative interpretation arrangements |
TC | Technical component | Use when billing only the technical component of the test (laboratory performs analytic work) |
59 | Distinct procedural service | Use when 83520 is distinct from other tests performed on the same day and not inclusive |
90 | Reference laboratory | Use when the specimen is sent to a reference laboratory for testing |
91 | Repeat clinical diagnostic laboratory test | Use when a repeat test is performed on the same day to obtain a separate result due to clinical reasons |
QW | CLIA waived test | Use when the test is performed using a CLIA-waived method (if applicable) |
QX | Ordering/servicing provider relationship - advanced practice practitioner billing under a physician | Use when applicable for billing relationships with advanced practice providers |
RT | Right side | Rarely used for laterality but included when anatomically relevant specimen laterality is required (not typical) |
XE | Separate encounter | Use when the service is performed at a separate encounter from other services billed the same day |
XS | Separate structure | Use when the test involves a separate specimen or operative site distinct from other services |
XU | Unusual non-overlapping service | Use when the test is distinct because it does not overlap with other services billed the same day |
GZ | Item or service expected to be denied as not reasonable and necessary | Use when there is no ABN or when expected denial applies (payer-specific policy) |
GA | Waiver of liability statement on file (ABN) | Use when patient signed an Advance Beneficiary Notice for Medicare-covered services not expected to be paid |
CR | Catastrophe/disaster related | Use when the service is provided as part of disaster response operations |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 208000000X | Anatomic and Clinical Pathology | Laboratory oversight, test validation, interpretation |
| 207R00000X | Clinical Pathology | Clinical laboratory services and assay operations |
| 363LA2200X | Laboratory Director | Laboratory management and regulatory compliance |
| 207K00000X | Hematopathology | Relevant if analyte relates to hematologic markers |
| 207L00000X | Chemical Pathology | Involvement for metabolic, endocrine, or toxicology analytes |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
E03.9 | Hypothyroidism, unspecified | Thyroid function tests and immunoassay-based hormone assays may be used when specific codes are not available |
E11.9 | Type 2 diabetes mellitus without complications | Immunoassays for peptide hormones or related biomarkers can be ordered for metabolic evaluation |
R53.83 | Other fatigue | Non-specific symptom prompting broad laboratory evaluation including specialized immunoassays |
C79.9 | Secondary malignant neoplasm of unspecified site | Tumor markers measured by immunoassay are used to monitor malignancy when specific codes are unavailable |
T50.995A | Adverse effect of other drugs, initial encounter | Therapeutic drug monitoring by immunoassay may be required for suspected drug toxicity |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
80053 | Comprehensive metabolic panel | Common concurrent chemistry panel that may be ordered with immunoassays for clinical correlation |
81002 | Urinalysis, non-automated, without microscopy | May be ordered in parallel for evaluation of systemic disease affecting analyte interpretation |
84443 | Thyroid stimulating hormone (TSH) | Example of a specific immunoassay code; used when a specific analyte has its own CPT rather than 83520 |
83516 | Immunoassay for infectious agent antigen detection (distinct) | Related methodology but for infectious antigens; differentiates infectious vs non-infectious analytes when coding |
88305 | Level IV surgical pathology, gross and microscopic examination | May be part of the broader diagnostic workflow when tissue correlation is needed |